PFE
Stock Details
PFE is Pfizer Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 50.60$. Average daily volumn in 3 months 24.51M. Market cap 293.51B
Stock symbol : PFE. Exchange : NYSE. Currency : USD Lastest price : 52.31$. Total volume : 16.14M. Market state PRE Click reload if you want to check the lastest price on market!!!
Pfizer Inc. (PFE)
Last Price
52.31$Change
-0.12Volume
16.14M
| Previous Close | 52.43 |
| Open | 52.04 |
| Day Range | 51.25-52.37 |
| Bid | 51.92 x 1k |
| Ask | 51.90 x 4k |
| Volume | 16.14M |
| Average Volume | 24.51M |
| Market Cap | 293.51B |
| Beta | 0.71 |
| 52 Week Range | 38.93-61.71 |
| Trailing P/E | 11.78 |
| Foward P/E | 0.96 |
| Dividend (Yield %) | 3.06% |
| Ex-Dividend Date | 2022-07-28 |
Financial Details
Organization
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 trea... tment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Market Cap:
293.51BRevenue:
81.29BTotal Assets:
181.48BTotal Cash:
1.94B
News about "Pfizer Inc."
Pfizer Inc. (NYSE:PFE) Shares Sold by Eastern Bank
Source from : Defense World - 7 hours ago
Eastern Bank lowered its stake in shares of Pfizer Inc. (NYSE:PFE – Get Rating) by 11.8% during the first quarter, according to the company in its most recent disclosure with the Securities and ...See details»
Busey Wealth Management Reduces Position in Pfizer Inc. (NYSE:PFE)
Source from : Defense World - 7 hours ago
Busey Wealth Management decreased its holdings in shares of Pfizer Inc. (NYSE:PFE – Get Rating) by 3.5% in the first quarter, Holdings Channel.com reports. The institutional investor owned 612,119 ...See details»
CureVac Sues BioNTech Over mRNA and Covid Vaccines. Pfizer Stock Isn’t Spared.
Source from : Barron's - 7 hours ago
CureVac says its intellectual property portfolio protects multiple inventions that are considered essential to Pfizer and BioNTech's Covid-19 vaccine.See details»
Pfizer's Updated COVID-19 Vaccine Effective Against Omicron, Could Boost Sales
Source from : Investopedia - 5 days ago
Pfizer's new COVID-19 vaccine candidate could be used as a fourth booster dose to protect against the Omicron variant, helping to further boost sales.See details»
Pfizer signs new $3.2 billion COVID vaccine deal with U.S. government
Source from : Reuters - 5 days ago
Pfizer Inc and partner BioNTech SE said on Wednesday they signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine, which could be delivered as soon as later ...See details»
Pfizer asks for formal U.S. approval of oral COVID treatment Paxlovid
Source from : Reuters - 5 days ago
Pfizer Inc said on Thursday it is seeking full U.S. approval for its oral COVID-19 antiviral treatment Paxlovid, which is currently available under an emergency use authorization (EUA).See details»
How Pfizer Won the Pandemic, Reaping Outsize Profit and Influence
Source from : Bozeman Daily Chronicle - 10 hours ago
The grinding two-plus years of the pandemic have yielded outsize benefits for one company — Pfizer — making it both highly influential and hugely profitable as covid-19 continues to infect ...See details»
Pfizer Seeks FDA’s Full Approval for Paxlovid Covid-19 Pill
Source from : Wall Street Journal - 5 days ago
Approval of Paxlovid, which has been available under an Food and Drug Administration authorization for use during the pandemic, would allow Pfizer to market and sell it commercially.See details»
Pfizer (PFE) Seeks FDA Nod for Its Oral Antiviral COVID Pill
Source from : YAHOO!Finance - 4 days ago
Pfizer (PFE) submits NDA to the FDA seeking approval for using its oral antiviral COVID pill in vaccinated and unvaccinated patients at a high risk of developing severe COVID-19 complications.See details»
Is Pfizer Inc. (NYSE:PFE) Popular Amongst Institutions?
Source from : YAHOO!Finance - 8 days ago
Every investor in Pfizer Inc. (NYSE:PFE) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see insiders owning shares ...See details»
Pfizer Inc. (PFE) Is A Good Investment At Current Valuations
Source from : stocksregister - 4 days ago
Pfizer Inc. (NYSE:PFE) at last check was buoying at $51.68 on Friday, July 01 with a fall of -1.43% from its closing price on previous day. Taking a look at stock we notice that its last check on ...See details»
Pfizer And BioNTech Reach New Agreement With U.S. To Provide Addl Doses Of COVID-19 Vaccine
Source from : Nasdaq - 5 days ago
Pfizer Inc. (PFE) and BioNTech SE (BNTX) have reached a new supply agreement with the U.S. government to provide additional doses of COVID-19 Vaccine, the companies said in a statement. Under the ...See details»
Pfizer Inc. (NYSE:PFE) Shares Sold by Pennsylvania Capital Management Inc. ADV
Source from : ETF Daily News - 7 days ago
Pennsylvania Capital Management Inc. ADV lessened its stake in Pfizer Inc. (NYSE:PFE – Get Rating) by 67.8% during the 1st quarter, according to its most recent 13F filing with the Securities & ...See details»
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
Source from : Yahoo News Singapore - 4 days ago
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.See details»